Agilent Technologies Inc. (NYSE: A) today announced its PD-L1 IHC 28-8 pharmDx kit has received two new companion diagnostic ...

Agilent PD-L1 IHC 28-8 pharmDx Receives EU IVDR Certification as a Companion Diagnostic Test for Non-small Cell Lung Cancer and Melanoma Indications Agilent Technologies Inc. (NYSE: A) today ...

Companion bills have been filed in the Texas Senate and House to prohibit individuals from using state-funded facilities that ...

Researchers from Creatv Bio, Division of Creatv MicroTech, Inc. (Monmouth Junction, NJ) and The Mayo Clinic (Jacksonville, FL), in collaboration with BriaCell Therapeutics Corporation (Philadelphia, ...

When used in conjunction with the PD-L1 IHC 28-8 pharmDx as a companion test ... patients 12 years of age and older with tumor cell PD-L1 expression < 1% that have previously untreated advanced ...

Busatta’s bill is an update to HB 379, which the Legislature unanimously approved in May 2023. That measure banned TikTok, ...

Grab this ultimately portable rechargeable speaker for your summer 2025 beach trips now while it's just $145 at Amazon.

Momentum Builds Across Programs with Key Data Milestones Expected in 2025Cemacabtagene Ansegedleucel (Cema-Cel): First-Line (1L) Consolidation in ...

Coeptis Inc. (Nasdaq: COEP) has taken a bold step forward in the fight against cancer by securing exclusive worldwide ...

I’m choosing a good old fashioned  non-electric, non-cell tower dependent device as the warning system at my house ...

The AI spreadsheet platform with Python integration, real-time collaboration, and advanced data visualization.